Outcomes show high rates of penile curvature improvement after CCH injections
November 10th 2021“Both [IMPRESS trials] would suggest that if patients are motivated to see if they can continue to improve their curvature and avoid things like surgery—which for many patients…is a goal—continuing with the collagenase makes good sense,” says Matthew J. Ziegelmann, MD.
Penile curvature improvement in Peyronie's disease assessed in post hoc analysis of IMPRESS trials
October 29th 2021“The goal of this study was to look at that original phase 3 trial data [from 2013] and see if we could identify how much change in curvature patients were achieving with each of those 2 injections,” says Matthew J. Ziegelmann, MD.
Benefits of testosterone therapy for patients with hypogonadism or type 2 diabetes
October 27th 2021“Most importantly, the improvement that they were able to get during the first couple of years is sustained, whereas what we expect in untreated men [is that] their erectile function…keeps on deteriorating,” says Karim Sultan Haider, MD.
Dr. Campbell assesses adverse effects of finasteride in patients with alopecia and BPH
October 25th 2021“This study suggests that the treatment of a patient's underlying hypogonadism or sexual dysfunction may be protective in the use of finasteride for alopecia or BPH,” says Kevin J. Campbell, MD, MS.
Study examines association between finasteride and suicidality, depression, and anxiety
October 23rd 2021“What we wanted to do was to substantiate any difference between BPH and alopecia with finasteride and also people who are concomitantly taking testosterone for hypogonadism,” says Kevin J. Campbell, MD, MS.
Regain of penile length not seen with collagenase clostridium histolyticum treatment
October 23rd 2021Although there was no significant change in the erect or the stretched penile length in patients who responded to the injections, results showed that there was a significant decrease in the erect circumference among the majority of patients.